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Review Article
Diet and heart disease •In the 1980s
CORONARY HEART DISEASE (CHD)
Fig. 1. A modern version of the diet-heart hypothesis2 (LDL =
Iow-density lipoprotein; HDL = high-density lipoprotein).
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Summary
~n ~ climate of increasing concern about the high
incidence of coronary heart disease in South Africa,
calls are increasingly being made for South Africans
to alter their diet. Can this exhortation be justified,
and are the right foods being singled out as culprits?
If changes in the eating habits of a nation are
advocated, the advice must not only be soundly
based in terms of likely benefit but must also take
account of potential hazards. Critical perusal of the
current literature leads to the conclusion that advice
promoting a fat-modified, lower-salt diet is sound,
safe and likely to be effective, especially as regards
the younger segment of the westernized population.
S Atr Med J 1983: 64: 437-442.
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The idea that food influences serum cholesterol (SC) levels and,
ultimately, the incidence ofcoronary heart disease (CHD) had its
. genesis in the cholesterol-fed rabbit experiments of Anitschkow
and ofIgnatowski in the first decade of this century. However, it
received its major impetus from Keys er al.'sl international
comparisons of fat intake, SC levels and CHD during the 1960s,
and has subsequently spawned a vast research effort and an
equally vast (and often contradictory) literature. Today, some
three-quarters of a century later, there is somewhat more clarity
about the diet-heart hypothesis (DHH), and in those areas where
there is not clarity the reasons for its lack are at least known.
Some unresolved challenges to the DHH remain. There are also
some rather exciting newer developments.
The hypothesis
The classic DHH can be rewritten to bring in an important,
oft-neglected feature, the time-scale2 (Fig. 1). While it takes only
days for dietary fat excess to elevate SC levels (step 1), it takes
decades for elevated SC levels to be translated into CHD (step 2).
The transition ofcoronary artery disease (CAD) into a myocardial
infarct or some other manifestation of CHD (step 3), on the other
hand, occurs in a matter of seconds or minutes. This scheme of
the DHH also takes cognizance of the influence of other dietary
indiscretions suspected of influencing the risk of CHD, namely
excessive kilojoule and salt intake. The long lag in time between
induction of hypercholesterolaemia and the development of
CHD, and the fact that epidemiological research has to rely on
manifestations of CHD rather than the precursor CAD as an
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endpoint, coupled with the confounding effects of many other
environmental and genetic influences upon the DHH pathway,
has made it difficult to validate the hypothesis completely.
The strongest evidence for step 1 comes from numerous
metabolic unit studies carried out in the 1950s and 1960s. These
studies, which were carried out under carefully controlled
conditions, enabled Keys er af.3 and Hegsted er al.4 to elaborate
formulae predicting the effect ofvarious dietary fat modifications
on SC levels. From these formulae it can be calculated that a
decrease in total fat intake to 20% of energ·y intake from a
previous 40%, and an increase in the dietary polyunsaturated/
saturated fat (P:S) ratio to 1,0 from 0,4 (keeping fat at 40% of
dietary energy), is equipotent in lowering SC levels by 15-18
mg/dl (0,3-0,5 mmol/l). Since a diet including 20% fat would be
unacceptable to most, it is of interest to note that a compromise
of a more modest fat reduction (to 30%) together with partial
substitution of polyunsaturated fat for saturated fat (P:S = 1) is
predicted to lower SC levels by 21 mg/dl (0,55 mmol/l). If, in
addition, dietary cholesterol intake is cut back to 200 mg from a
previous 500 mg, a total reduction of29 mg/dl (0,75 mmol/l) can
be obtained. In each of these cases the major part of the benefit
would be obtained from the reduction in saturated fat intake.
The most compelling evidence in support of steps 2 and 3
combined, that raised SC predisposes to CAD + CHD, comes
from prospective epidemiological studies such as the Pooling
Project, which combines data from several American studies.s
This study and several others have shown that the risk of
mortality from CHD starts rising after the SC level reaches
about 220 mg/dl (5,7 mmol/l), and suggests that in the higher
ranges of SC the risk may even become exponential.
On the basis of these and other considerations, numerous
learned bodies have recommended modification of the typical
Western diet in order to lower the risk of CHD, the most well
known of which is the McGovern Committee's Dierary Goals for
rhe Unired Srares. 6 Basically, all have urged weight control, a
reduction in intake of fat, especially saturated fat, partial
substitution of polyunsaturates for saturates, and reduction in
cholesterol intake. Concomitantly, the complex carbohydrate
intake is increased to compensate for the reduced fat intake.
Some have also advocated reduced salt intake. Most, but nor all,
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TABLE I. DIET AND HEART DISEASE - THE EVIDENCE
FOR AGAINST
The role of certain foodstuffs - some
controversies
Perhaps the most important observation to be made from
these and four other dietary intervention trials is that all showed
the same trend towards lower mortality and morbidity from
CHD.IO A primary prevention trial ofsufficient statistical power
to prove or disprove regression is unlikely ever to be carried out
since it would require about 60 000 participants to be followed up
for 10 years, I1 so that decisions about causality will, perforce,
have to be taken on the basis of the present evidence.
The literature is replete with conflicting statements about the
contributions of individual food components to risk of CHD, e.g.
eggs, milk, margarine, sugar, fibre and salt. The controversies
are partly due to the enormous variety of foodstuffs which
interact and contribute towards serum lipid levels. The role of
any single foodstuff is therefore likely to be modest; the
cumulative effect ofmany different foods determines a favourable
or unfavourable lipid profile. Only under strictly controlled
conditions is it possible to isolate the effect of single foods.
2. Within population groups the
associations between diet and
serum lipids are frequently
unimpressive
3. Dietary intervention trials
have generally been inconclu-
sive
4. Results in animal experi-
ments cannot be extrapolated
to humans
1. Associations do not prove
causality
3. Inter- and intrapopulation
association of SC (and certain
Iipoproteins) with CHD
4. Metabolic studies in animals
and humans confirm effect of
dietary lipids on SC
5. In animals atherosclerosis
can be induced by high-lipid
diets and regressed by low-
lipid diets
6. Arterial lesions in animals
and humans with certain hyper-
Iipaemias contain excessive
cholesterol
7. Certain genetic hyperlipae-
mias established in early life
show premature CHD
1. Interpopulation associations
between consumption of cho-
lesterol, total and saturated fat,
and SC
2. Interpopulation associations
between dietary lipids and
CHD
the number of fatal infarcts was not significant. Non-fatal
infarcts were significantly reduced in both, most notably so in
the Helsinki study. Non-cardiovascular mortality increased in
both studies, but overall mortality was similar in both the
experimental and the control group. Ifone keeps in mind the fact
that these were not primary prevention trials since many of the
subjects already had arterial disease of long duration owing to
their age, it is surprising that any favourable effect could be
demonstrated at all. In addition, these were not trials of the
'prudent diet', since the total fat (and, in Helsinki, cholesterol)
intake was not reduced. In consequence, the lowering in SC
levels achieved was rather modest (12-18%).
have recommended that these changes be adopted by the entire
westernized population, not only those with elevated SC levels.
Since such a recommendation may affect many people -
perhaps half of the population - who are not at risk, it behoves
nutritional scientists to examine the quality of the evidence for
causality in the DHH very carefully indeed. This has been ably
done by Hulley er aP The kinds of evidence they consider are:
non-epidemiological (pathophysiology studies, clinical cases of
rare lipid disorders, and animal studies); observational epidemio-
logical (international comparisons, secular trends, cross-sectional
and prospective studies of individuals); and experimental or
interventional epidemiological (metabolic ward studies, trials of
CHD prevention).
Support for step 1, that diet influences the SC level, is
moderately strong from animal-feeding experiments and also
from international comparisons of diet and SC levels such as
Keys er al.'s seven-country study. Secular trends in the USA,
such as a reduction in SC pari passu with reductions in national
consumption of saturated fats and cholesterol, provide mild
evidence, as do studies of individuals within a community. The
strongest evidence comes from metabolic ward studies of
individuals and dietary trials of CHD prevention in populations.
The latter have consistently shown a 10-15% reduction in SC
levels.
For step 2, that a high SC level predisposes to CAD, moderate
evidence is forthcoming from postmortem and angiographic
studies, rare cases oflipid disorders such as familial hypercholes-
teroiaemia, and animal studies. For step 3 (CAD - CHD)
pathological studies indicate that almost all CHD patients have
pre-existing CAD, including those with rare lipid disorders.
International comparisons, secular trends and prospective studies
all provide mild-to-moderate evidence of causality for steps 2
and 3 combined, while intervention studies have been inconclu-
sive.
Ability to prove causality by some of these approaches is
inherently limited, but the accumulated evidence is strongly in
its favour (Table I). The arguments most commonly used to
refute the DHH include statements that associations in population
studies cannot prove causality, that within such populations the
association between diet and SC levels or CHD is frequently
unimpressive, that intervention trials have generally yielded
disappointing results, and that results in animal studies cannot
be extrapolated to humans.
The first of these arguments is valid, and reflects an inherent
limitation ofobservational epidemioiogy. However, the strength
of the association between SC levels and CHD, the dose-
response relationship and the consistency with which it is found
in many studies are in favour ofcausality. 7 With regard to the last
point, if animal experiments cannot (with the necessary circum-
spection) be applied to humans, then much of medical science
would have to be consigned·to the waste-paper basket. The
inability to show a relationship between diet and SC levels within
a population should not surprise anyone, given the relative
homogeneity of such a diet, variable individual responses, and
the imprecision with which food intakes can be measured. In
spite of these handicaps, studies have given positive results, the
most recent of which was the Western Electric Study.s This
study showed intrapopulation correlations between SC levels
and dietary saturated fatty acids as well as with the dietary score
of Keys er al. It also showed a significant association between
changes in SC levels 19 years later and changes in saturated fatty
acid intake, cholesterol intake and the score of Keys er al.
The criticism that dietary intervention trials have not lowered
mortality from CHD has some validity, as indicated by inspection
ofdata from the two best-eontrolled studies, the Helsinki Mental
Hospital Study and the United States Veterans Administration
(VA) Study.9 Both studies used a high P:S ratio diet without
lowering total fat intake. Cholesterol intake was modestly
reduced in the VA trial (to about 365 mg/d), but the reduction in
-Eggs
Eggs are the richest source of dietary 'cholesterol, and before
1972 no less than 10 reports of rigorously controlled, albeit
short-term, metabolic ward studies uniformly showed that egg
consumption raised se levels by a mean of 19%. Subsequently a
number of egg supplementation studies in free-living and in
hospitalized subjects failed to show such a relationship. These
non-metabolic ward studies suffer from the drawback that they
were not always possible to. control - did the subjects actually
eat the eggs, and if they did what other adaptations did they make
in their diets? Recently, Roberts ec al.12 conducted a unique
experiment in which half a cup of egg (± 400 mg cholesterol)
daily or a cholesterol-free egg substitute was administered to
free-living subjects for 4 weeks in a double-blind, cross-over
design such as is used for drug trials. The results were
unequivocal: whole eggs raised the se level and the egg
substitute did not. This study can be regarded as definitive as
regards the short-term effect of eggs on the se level. Results of
similar egg-feeding studies over a longer term have not yet been
reported.
Milk
The fats of whole milk are almost wholly saturated, and it
would therefore be expected to raise se levels if taken in
sufficient quantity. Indeed, feeding with butterfat is one of the
most efficient ways ofinducing hyp:::rcholesterolaemia in animals.
However, a number of workers 3-15 have suggested that full-
cream milk (especially in the form of yoghurt) contains some
substance in the aqueous phase (the 'milk factor') which actually
lowers Se. Recent attempts in South Africa, Finland and
Australia l6- 18 to reproduce these results in humans have been
uniformly unsuccessful. In the South African study full-cream
milk and yoghurt increased se during the first 2 weeks of a
3-week period, while only skim milk decreased it. The results
were consonant with the reported changes in dietary fat and
cholesterol intake induced by consuming 2 litres ofeach product.
However, it is worth noting that the increases in se levels in both
the South African and the Australian studies were only about
two-thirds of that predicted by the equation of Keys er al. These
results were subsequently confirmed in a longer, 6-week study
(J. E. Rossouw ec al. - unpublished observations). It may
therefore be concluded that South African cows do not produce
the 'milk factor', or produce it in insufficient quantities!
Margarine
In nature polyunsaturated fatty acids are folded back upon
themselves at the double bond (the cis form), but during partial
hydrogenation double bonds are broken and reformed so that
some fatty acids end up in the rrans form, with the carbon
skeleton strung out on either side of the double bond. Trans fatty
acids have no essential farty activity, even if they are polyunsa-
turated. 19 Their effect on se is about midway between that of
mono-unsaturated and that of saturated fatty acids. 20 They
should therefore probably be grouped with saturated fatty acids.
Unfortunately, at present the South African public has no way of
knowing the rrans fatty content of margarines, which may be as
high as 20% in polyunsaturated margarines and even higher in
brick-form margarines. The effective P:S ratio of a polyunsa-
turated margarine may thus be only 1,0 as against the expected
2,0. Since a ratio of2,0 is technologically feasible, food-labelling
legislation is urgently required to correct this anomalous situation.
Such legislation could also expose the hollowness of advertising
claims that certain brands contain 0% cholesterol. All South
African margarines are made from sunflower oil and contain no
cholesterol; their effect on serum cholesterol levels therefore
depends entirely on the P : S ratio. It should be noted that even at
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a P : S ratio of 2,0, margarine has a neutral effect on serum
cholesterol. Only in comparison with butter can it be said to have
a favourable effect.
Sugar
Countries with a high per capita consumption ofsugar tend to
have a high rate of CHD.21 However, owing to socio-economic
reasons sugar consumption is closely linked to fat intake.
Multivariate analyses of cross-cultural data have generally
shown no indegendent effect ofsugar consumption on mortality
from CHD.21 . Sugar does not appear to influence low-density
lipoprotein (LDL) cholesterol, but may increase triglycerides23
and decrease high-density lipoprotein (HDL) cholesterollevels.24
In the main, the evidence linking sugar and CHD is not very
persuasive. .
Fibre
Wheat bran, the kind of fibre obtained from eating wholewheat
bread and 'high-bulk' breakfast cereals, has very little or no
effect on serum lipid levels. 25 Oats do seem to lower LDL
cholesterollevels,26 as does food fibre from legumes, vegetables
and fruits, i.e. gums and pectins.27 It is of interest that the
reduction in SC levels induced by food fibres is not usually
associated with any reduction in HDL ~holesterol.26 The
mechanism of the hypocholesterolaemic effect of fibre may
involve increased faecal bile-acid loss.26 In cross-cultural studies
total food fibre intake is negatively correlated with fat intake, and
a low fibre intake may therefore appear to be associated with
CHD in univariate analyses. When the interaction with fat intake
is controlled for, no significant effect of food fibre intake
remains. 22
Salt
In international comparisons there is a clear relationship
between salt consumption and rise in blood pressure with age.
Populations consuming 5 g or less of salt per day do not show
such a rise, while those consuming 10 g or more (as is the case in
most Western cultures) do experience an increase in blood
pressure with age. As with dietary fats and se levels, it is likely
that only those individuals with a constitutional predisposition to
hypertension will develop it, given a uniformly high exposure to
dietary salt. It is therefore unlikely that an association between
salt intake and hypertension will be very striking within a
community.2B
While there is no doubt that extreme low-salt diets (such as the
Kempner rice diet) lower blood pressure, these are extremely
unpalatable. There has been some controversy about the effects
of more moderate salt restriction, to say 5 g/d. MacGregor er
al. 29 have recently provided an elegant answer. By using the
double-blind placebo-controlled cross-over technique they could
show that moderate salt restriction lowered blood pressure in
patients with mild hypertension, and that this reduction was
maintained on placebo but reversed when slow-release sodium
tablets were given to return the salt intake to pre-diet levels. The
dietary advice given was simply to abstain from excessively salty
foods and to add no salt during the cooking of food or at the table.
Potential hazards of lowering se levels
Before recommendations about lowering se levels can be made
to the general public, it is essential to be sure that these measures
are not only effective but also safe. Some of the putative hazards
are cancer, gallstones, a lowering of HDL cholesterol levels and
an increase in overall mortality. These are discussed below.
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Cancer
Carcinogenicity is an emotive issue and worthy of serious
consideration, since animal experiments do show that polyunsa-
turated fatty acids have some co-earcinogenic potential.30 The
Los Angeles VA trial also suggested a higher incidence ofcancer
among the treated group, but pooling of the data with those from
four other smaller diet trials provides some reassurance that
there is no overall increased risk of cancer. 31 In the VA trial the
cancers developed most frequently in those ingesting the
smallest amount of the experimental diet. The large recently
published Oslo trial also provided no evidence of increased
cancer mortality.32 Indeed, it would be surprising if such a
relationship existed, since in humans the best epidemiological
correlation with the occurrence of certain cancers (e.g. of the
breast, prostate and colon) is that of total fat intake. Reduction in
fat intake, especially if coupled with a more vegetarian, high-
fibre eating pattern, is more likely to reduce than to increase the
risk of cancer.
Gallstones
The evidence for a greater incidence of gallstones again rests
upon the VA diet trial,33 and to a lesser extent the World Health
Organization clofibrate triaJ.34 In the latter it is of course
impossible to separate the direct effect ofclofibrate from that ofa
lowering of cholesterol. The same comment holds for the
reported (not significant) excess of cancer in the clofibrate trial.
The VA study was the only diet trial to report an increased
incidence ofgallstones. Human experiments show that increased
flux ofbiliary sterols occurs upon changing from a high saturated
to a high polyunsaturated fatty acid diet, but this appears to be a
transient phenomenon.35 Whether this effect is sufficient to
precipitate gallstone formation is still an open question. Prelimi-
nary data from a primate study indicate that the 'prudent' diet is
likely to be less lithogenic than the 'Western' diet (J. E. Rossouw
et al. - unpublished observations).
HDL cholesterol
What about HDL cholesterol? Early work using unrealistically
high P:S ratios showed a decrease in presumably protective
HDL levels in subjects on diets high in polyunsaturates.36 Most
subsequent studies have shown either no effect or a lesser
reduction in HDL than in LDL cholesterol on diets closer to the
'prudent diet,.27, 32 The net effect is usually an increase in the
HDLLDL cholesterol ratio.
Overall mortality
Very recently a number of prospective studies have shown a
I-shaped relationship between SC level and overall mortality,
with more cases ofcancer of the colon among men and ofstrokes
among women at the lower end of the cholesterol distribution.37
The reasons for these associations are obscure. In some studies
the association was only evident for the first 2 years of follow-up,
suggesting that the neoplasm was already present at the time of
screening.38 Another possibility is that people with low SC levels
are efficient excretors of dietary cholesterol, and that their high
faecal sterol levels predispose them to cancer of the colon.39 If
this is so, then a low-fat, high-fibre diet which reduces faecal
sterol concentrations27 should be advantageous rather than
deleterious. In any event, the association between low SC levels
and overall mortality does not, on the basis of present evidence,
provide any compelling reason to modify advice regarding
reduction of SC, since this reduction does not appear to be
associated with an increased risk ofcancer. In addition, it should
be borne in mind that many peoples who have enjoyed a low-fat
diet all their lives as well as those who have adopted it in later life
(e.g. vegetarians) seem to have a singularly low rate of colon
cancer as well as of CHD.
Alternative diets
Where do we go from here? Are there any other fruitful avenues
which can be explored in search of an alternative diet? The very
low fat diet (the 'longevity' diet) advocated by Pritikin, which
provides only 10-20% of dietary energy in the form of fat, makes
good sense on a superficial level since populations consuming
such a diet experience virtually no CHD. However, it is likely
that the low saturated fat content of such a diet is the important
factor, since some populations, e.g. Cretans, with a high fat
intake of mainly the mono-unsaturated type have a low incidence
of CHD.21 The unacceptability of the 'longevity' diet to the
Western palate is its main disadvantage. Of interest in the South
African context is the fact that the 'longevity' diet is fairly close to
the traditional diet of Blacks, and the incidence of CHD is very
low in Blacks.
The Mediterranean diet with its moderately low total fat
content (mainly mono-unsaturates, very low in saturates), low
cholesterol and animal products and high carbohydrate content
may be a more acceptable alternative. CHD mortality is low in
Mediterranean countries,21 and when an Italian diet was fed to
North Karelian families a decrease in SC levels of 20% was
induced. Interestingly, blood pressures also fell in spite of an
unchanged salt intake (J. K. Huttunen - personal communi-
cation).
0liver9 has promoted the idea that a relative deficiency' of
essential fatty acids may be important in some circumstances,
and cites the Scots as an example ofa population with a high rate
of CHD and a low linoleic acid content intake in cholesteryl
esters, while their SC levels are not particularly high. The Scots
do have a low « 3% ofdietary energy) intake of polyunsaturated
fatty acids and this suggests the attractive possibility that simply
supplementation with polyunsaturated fany acids may ameliorate
the CHD problem. This suggestion has not been put to the test of
an intervention study, but it seems unlikely that such a
mechanism is of importance except in very unusual circum-
stances. Populations consuming polyunsaturated fatty acids to
the degree of 4-8% of dietary energy (e.g. American Whites35)
have a CHD rate similar to that of the Scots.
The very low apparent incidence of CHD among Eskimos,
who largely subsist on fish, seal meat and blubber, has stimulated
interest in the biological effects of the marine oils. Eskimos have
very low linoleic acid levels in their cholesteryl esters, but high
eicosapenta-enoic acid levels.9 Unsaturated fats are classed into
the w9, w6 or w3 series according to where the first double bond
lies from the methyl end. Oleic acid (CI8: I), the main represen-
tative ofthe w9 family, is non-essential since it can be synthesized
in the body. The w6 family is the common polyunsaturated
family, with linoleic acid (CI8:2) most common. It is found in
vegetable oils, is essential, and is a precursor of prostaglandins.
w3 fatty acids are found mostly in marine oils, and only to a
limited extent in seeds and leaves. In marine oils eicosapenta-
enoic acid (C20:S) predominates, while in seeds a-linolenic acid
(CI8:3) predominates.
'Fish oils are particularly interesting since they are at least as
effective as vegetable oils in reducing SC levels and more
effective in reducing serum triglyceride levels, but do not affect
HDL cholesterol.35 Much recent interest has centred around the
effects of polyunsaturated fatty acids on platelet and vessel wall
function. Linoleic acid is converted in the platelet to a throm-
boxane (TXA2) which is pro-aggregatory, while in the vessel wall
it is converted to an anti-aggregatory prostacyclin. Similarly, fish
oils such as eicosapenta-enoic acid are converted to a throm-
boxane, but this thromboxane is inactive. More importantly,
eicosapenta-enoic acid decreases the arachidonic acid concentra-
tion of platelets, and blocks TXA2 synthesis from it. The net
effect is anti-aggregatory to such an extent that bleeding time is
prolonged.35 Although other polyunsaturated fany acids may be
anti-aggregatory, fish oils are unique in this respect. Perhaps this
is the secret of the Eskimos' immunity to CHD; if so, it vividly
illustrates that the effects of dietary fats and oils go beyond their
influence on serum lipids.
Potential benefits of the 'prudent diet'
A diet which is fat-modified, high in food fibres and low in salt
may have advantages (Table 11) other than lipid-lowering
qualities, although these benefits need to be confirmed. They
include reduced thrombogenicity of blood via the effect of
polyunsaturated fany acids on platelets, referred to above. In
contrast, saturated fany acids actually increase blood thrombo-
genicity.35 Preliminary human studies indicate that blood pressure
may be lowered by a fat-modified diet, even in the absence ofsalt
restriction;4o this effect may be mediated by prosraglandins in
the kidney.41 Lowering of SC levels may, in addition: reduce
vascular reactivity to catecholamines.42 Glucose tolerance may
improve,43 although the mechanism for this improvement is
ill-understood. A high-fibre, high-earbohydrate diet has been
shown to improve diabetic contro1.44 It is likely that such a diet
will reduce rather than increase the risk of colon and other
cancers. High fibre intake may also have other beneficial effects
on bowel function. It has been suggested that such a diet will
result in less constipation, diverticulosis, appendicitis, haemor-
rhoids and gallstones.45 High salt intake is epidemiologically
associated with gastric cancer,46 as well as with hypertension;
reduced intake may conceivably have benefits beyond lowering
of blood pressure.
TABLE 11. POTENTIAL BENEFITS OF THE 'PRUDENT DIET'
Lowering of se and LDL cholesterol levels
Reduced blood thrombogenicity
Reduced blood pressure
Improved glucose tolerance
Reduced risk of cancer
Improved large-bowel function
Who should be the target population?
If we accept that the 'prudent diet' is beneficial and safe, the
next question that arises concerns the groups on which interven-
tion should be focused. Clearly certain individuals exposed to a
westernized dietary milieu will be more 'at risk' of CHD than
others owing to the fact that they have responded to that
milieu by developing hypercholesterolaemia, hypertension,
hyperglycaemia or obesity. Together with cigarette smokers,
they will form the majority. The great bulk of future CHD
victims will come from their ranks.47 Should intervention be
aimed only at them? The first and major problem with such an
individualized 'medical' approach is that these high-risk persons
would first have to be identified. Ifan appreciable proportion are
to be identified, massive screening programmes would have to be
undertaken in our high-risk populations, i.e. the Whites, Indians
and urban Coloureds. Such programmes are clearly not feasible
either from an economic or a logistic viewpoint. If intervention is
to be reserved only for those who have presented themselves to
the health care system, it will have a very limited impact on the
total problem of CHD, not least because many members of this
self-selected population are already suffering from the complica-
tions of atherosclerosis and would therefore not benefit much
from secondary prevention. In addition, employment ofconven-
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tional cur-off points for SC and blood pressure in order to
identify high-risk individuals will miss those who fall ourside the
upper quintile of the risk factor distribution, but who will
nevertheless develop CHD owing to modest elevations coupled
with other constitutional and environmental predispositions.
The alternative approach is to treat the entire westernized
community as being 'at risk'. Community intervention would
almost certainly be more rewarding than individual intervention,
since the high-risk segment would be more likely to follow
dietary and other lifestyle modifications if it became the
community norm. The purpose ofsuch intervention would be to
shift the distribution of risk factors to the left. Even a modest
shift of, for instance, total cholesterol levels could have a
significant impact on CHD mortality rates, since it can be
p~edicted that a 1 mg/dl (0,025 mmo1/1) decrease in mean SC
may diminish the number ofdeaths from CHD by 1%.2Ifall the
elements of the fat-modified diet were to be complied with, the
resultant 29 mg/dl (0,75 mmo1/1) decrease in the mean SC level
would then predict a similar decrease in CHD. If other dietary
modifications are made, such as a reduction in energy, increase in
food fibre and decrease in salt intake, the potential savings in
lives could become truly remarkable. However, the objectives
should be kept realistic since changes in community habits
would by their very nature be slow to materialize. The time-span
is also a long one, since the 'incubation period' for risk factor
expression as CHD is at least 2 decades.48 Maximal regression
may well have a similar time-scale. Potentially the most rewarding
segment of the community would be the young, since true
primary prevention would be possible in them. Established
fibrotic plaques in the middle-aged are less likely to benefit from
a reduction in SC, as judged from primate regression experi-
ments.
Conclusions
Study of the facts at our disposal in 1982 leads to the conclusion
that certain dietary modifications are very likely to be effective in
reducing the incidence of CHD, and that they are safe. They
include energy management in order to achieve and maintain
near-ideal body mass, a lowering of total fat intake and especially
a reduction of saturated fat intake to <30% of energy, a modest
increase of polyunsaturated fatty acid (especially from fish)
intake, a lowering of cholesterol intake to less than 300 mg (250
mg for women) per day, an increase in food fibre intake
(especially from fruits and vegetables), and a reduction in salt
intake to less than 5 g/d. Such a diet can be expected to lower the
incidence of mortality from CHD, strokes and certain forms of
cancer, and not to create new health hazards. It is also practical
since the modifications needed are relatively modest, and makes
economic sense because the increased emphasis on plant proteins,
oils and fibre and on fish would ease the pressure on the
householder's budget due to the high cost of producing animal
proteins and fat. If the agricultural sector takes note of buying
trends resulting from an active heart health campaign and makes
the necessary adaptations timeously, there is no need for any
particular sector to be economically disadvantaged. An ever-
growing population will still have to be fed.
Rigorous scientific proof to substantiate some of these recom-
mendations is lacking, but the weight and diversity ofevidence in
favour of them is such that they can be accepted as being proven
beyond reasonable doubt. It is noteworthy that in countries
where public education campaigns towards a healthier diet have
been in progress for some years, such as Australia and the USA,
the mortality rate from CHD is falling. In England, where the
DHH is still regarded with some scepticism, the rate has
remained constant.50 Of course, diet is not the only lifestyle
factor to have improved in those countries in which mortality
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from CHD is declining: better control of blood pressure, a
decrease in smoking and increased leisure-time activity may all
have contributed, together with improvement in the management
of myocardial infarctions. Nevertheless, these favourable trends
do make the point that death from CHD is preventable.
Finally, the most sensible target group for intervention should
be the entire westernized population, with special emphasis on
the young and on the need for lifelong maintenance of a healthy
lifestyle. Hopefully the hard lessons learned by westernized
communities will be used to advantage to prevent those segments
of the South African society not yet so compromised from
making the same mistakes.
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